HOME
THE APPROACH
ARENAVIRUSES AS THERAPEUTICS
SCIENTIFIC FOUNDATION
HARNESSING THE MAMMARENAVIRUSES
MECHANISM OF ACTION
PUBLICATIONS
THE TEAM
MANAGEMENT & BOARD
INVESTORS & PARTNERS
NEWS & EVENTS
CAREERS & CONTACT
CAREERS
CONTACT
© Abalos Therapeutics 2019
HOME
MENU
News & Events
SCROLL DOWN
Press Releases
Stay up to date on the latest company news:
18 October 2022
Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer
Read full Press Release here
12 August 2022
Abalos Therapeutics---arenaviruses take on cancer
Read full Press Release here
14 October 2021
Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million
Read full Press Release here
05 February 2020
Abalos Therapeutics Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts
Read full Press Release here
15 October 2019
Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer
Read full Press Release here
Events
Want to get in touch with the Abalos Therapeutics Team? Meet us at the following events:
Coming soon
Consent Management Platform by Real Cookie Banner